<SUBMISSION>
<SECRELEASE-DATETIME> 20220329-101554 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20220329-101536 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20220329-101500 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0001640334-22-000599
<TYPE> F-3
<PUBLIC-DOCUMENT-COUNT> 5
<FILING-DATE> 20220329
<DATE-OF-FILING-DATE-CHANGE> 20220329
|
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME> NYMOX PHARMACEUTICAL CORP
<CIK> 0001018735
<ASSIGNED-SIC> 2835
<IRS-NUMBER> 000000000
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> F-3
<ACT> 33
<FILE-NUMBER> 333-263932
<FILM-NUMBER> 22778282
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 9900 CAVENDISH BLVD., SUITE 306
<STREET2> ST. LAURENT
<CITY> QUEBEC CANADA
<STATE> A8 ⇐ This is an SEC Country/Territory Code for
Quebec, Canada {CA|CAN}
<ZIP> H4M 2V2
<PHONE> 1-800-936-9669
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 9900 CAVENDISH BLVD., SUITE 306
<STREET2> ST. LAURENT
<CITY> QUEBEC CANADA
<STATE> A8 ⇐ This is an SEC Country/Territory Code for
Quebec, Canada {CA|CAN}
<ZIP> H4M 2V2
</MAIL-ADDRESS>
</FILER>
|
<DOCUMENT>
<TYPE> F-3
<SEQUENCE> 1
<FILENAME> nymox_f3.htm
<DESCRIPTION> F-3
<TEXT>
<html>
Show <HTML>: 1 lines (widest: 257,334 characters) - 252K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> EX-5.1
<SEQUENCE> 2
<FILENAME> nymox_ex51.htm
<DESCRIPTION> EX-5.1
<TEXT>
<html>
Show <HTML>: 1 lines (widest: 13,715 characters) - 14K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> EX-23.1
<SEQUENCE> 3
<FILENAME> nymox_ex231.htm
<DESCRIPTION> EX-23.1
<TEXT>
<html>
Show <HTML>: 1 lines (widest: 2,138 characters) - 3K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> EX-FILING FEES
<SEQUENCE> 4
<FILENAME> nymox_ex107.htm
<DESCRIPTION> EX-107
<TEXT>
<html>
Show <HTML>: 1 lines (widest: 11,507 characters) - 12K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> GRAPHIC
<SEQUENCE> 5 ⇐ Not a Document/Exhibit
<FILENAME> nymox_f3img1.jpg
<TEXT>
Show <TEXT>: 69 lines (Unix-to-Unix encoding) - 5K bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
| ↑Top |
